Experts close the discussion by sharing insights on the future in advanced RCC, emphasizing the development of emerging agents and combination regimens for the treatment landscape.
Anwaar Saeed, MD, and Amit Singal, MD, discuss the evolving treatment landscape for hepatocellular carcinoma, highlighting FDA approvals and the utility of clinical biomarkers.
Dublin, Dec. 11, 2023 (GLOBE NEWSWIRE) The "Chronic Hepatitis B - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Global Perspective on Chronic Hepatitis B: Insights into Market Trends, Epidemiology, and Future Treatment ProjectionsThe latest research publication on Chronic Hepatitis B offers comprehensive market insights, epidemiological trends, and forecasted data till the year 2032. Chronic Hepatitis B, a widespread infec
Atta Chowdhry, RPh, and Robert Sidonio Jr, MD, MSc, discuss the safety and efficacy of gene therapy for hemophilia A, highlighting recent approvals, with insights into adverse effects, immunosuppression, and the evolving treatment landscape.